Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis
ID：am030003M00350707ysij7📫 9页
内容摘要
Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis
海外数据平台所有内容均是公开网络、AI代理代查、客户上传分享、合作方，仅供网友学习交流，请勿商用!
